Safety of Abatacept in Rheumatoid Arthritis Associated Interstitial Lung Disease: A Feasibility Trial
Phase of Trial: Phase II
Latest Information Update: 27 Aug 2018
At a glance
- Drugs Abatacept (Primary)
- Indications Interstitial lung diseases; Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms APRIL
- 31 Aug 2018 Biomarkers information updated
- 16 Aug 2018 Planned End Date changed from 1 May 2020 to 1 Mar 2020.
- 16 Aug 2018 Planned primary completion date changed from 1 May 2020 to 1 Mar 2020.